PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
17573462-4	2007	Administration of glucosamine (10 mM) or an inhibitor of O-GlcNAcase, O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc; 200 microM), during the first 20 min of reperfusion significantly improved cardiac functional recovery and reduced troponin release during reperfusion compared with untreated control.	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	70-138	O-GlcNAcase	Rattus norvegicus	57-68
16365142-7	2006	Conversely, treatment with the beta-N-acetylglucosaminidase inhibitor, O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate, in the presence of normal glucose increased Sp1 O-GlcNAcylation and PAI-1 mRNA and protein levels.	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	71-139	O-GlcNAcase	Homo sapiens	31-59
17142462-9	2007	Consistent with this observation, inhibition of N-acetylglucosaminidase, the enzyme involved in the removal of the O-GlcNAc modification from proteins, with O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate stimulates MafA expression under low glucose conditions.	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	157-225	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	115-123
17142462-9	2007	Consistent with this observation, inhibition of N-acetylglucosaminidase, the enzyme involved in the removal of the O-GlcNAc modification from proteins, with O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate stimulates MafA expression under low glucose conditions.	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	157-225	MAF bZIP transcription factor A	Homo sapiens	237-241
16365142-7	2006	Conversely, treatment with the beta-N-acetylglucosaminidase inhibitor, O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate, in the presence of normal glucose increased Sp1 O-GlcNAcylation and PAI-1 mRNA and protein levels.	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	71-139	serpin family E member 1	Homo sapiens	209-214
15843043-4	2005	Treating cells with either 8 mM d-glucosamine (GlcN), 5 mM streptozotocin (STZ), or 80 muM O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc) produced a significant increase in the O-GlcNAc modification on both cytosolic and membrane proteins; however, both the level and rate of O-GlcNAc increase varied with the compound.	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	91-159	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	208-216
15843043-4	2005	Treating cells with either 8 mM d-glucosamine (GlcN), 5 mM streptozotocin (STZ), or 80 muM O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc) produced a significant increase in the O-GlcNAc modification on both cytosolic and membrane proteins; however, both the level and rate of O-GlcNAc increase varied with the compound.	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	91-159	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	307-315
11959983-3	2002	Cycling of the O-GlcNAc posttranslational modification was blocked by pharmacological inhibition of O-GlcNAcase, the enzyme that catalyzes O-GlcNAc removal from proteins, with O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc).	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	176-244	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	15-23
11959983-3	2002	Cycling of the O-GlcNAc posttranslational modification was blocked by pharmacological inhibition of O-GlcNAcase, the enzyme that catalyzes O-GlcNAc removal from proteins, with O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc).	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	176-244	O-GlcNAcase	Homo sapiens	100-111
11959983-3	2002	Cycling of the O-GlcNAc posttranslational modification was blocked by pharmacological inhibition of O-GlcNAcase, the enzyme that catalyzes O-GlcNAc removal from proteins, with O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc).	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	176-244	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	100-108
15703172-3	2005	Here, we extend this correlation by showing that a mechanistically distinct means of increasing O-GlcNAc, achieved by inhibition of O-GlcNAc removal with O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc), increases basal cellular motility and directional migration induced by the chemoattractant formyl-methionine-leucine-phenylalanine (fMLP).	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	154-222	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	96-104
15703172-3	2005	Here, we extend this correlation by showing that a mechanistically distinct means of increasing O-GlcNAc, achieved by inhibition of O-GlcNAc removal with O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc), increases basal cellular motility and directional migration induced by the chemoattractant formyl-methionine-leucine-phenylalanine (fMLP).	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	154-222	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	132-140
15703172-3	2005	Here, we extend this correlation by showing that a mechanistically distinct means of increasing O-GlcNAc, achieved by inhibition of O-GlcNAc removal with O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc), increases basal cellular motility and directional migration induced by the chemoattractant formyl-methionine-leucine-phenylalanine (fMLP).	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	154-222	formyl peptide receptor 1	Homo sapiens	365-369
9452489-0	1998	Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.	o-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-n-phenylcarbamate	160-228	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	112-120